Strategy and Approach
Grey Sky Venture Partners focuses on discovering and funding exceptional management teams developing compelling, well-protected innovations springing from leading-edge research that have the potential to significantly impact the complex and rapidly changing healthcare system.
We make early-stage investments in healthcare and medical technology companies that seek to improve clinical outcomes, enhance quality of life, or reduce system costs. With a heritage rooted in invention, Grey Sky also brings intellectual property expertise and access to a patent portfolio that can be strategically valuable to young companies.
Grey Sky identifies new early-stage investment opportunities by tapping into a broad network of industry relationships and through screened thematic research into emergent diagnostic and therapeutic areas in healthcare. Following our initial investment, we work closely with portfolio companies and syndicate partners to develop and implement strategic plans, achieve operating objectives, build great teams, raise additional capital, and pursue liquidity opportunities in a manner that optimizes returns to all stakeholders.
Our company name was inspired by the frequently cloudy skies of the verdant Pacific Northwest, a region to which the fund has important ties; our logo features Mount Rainier, the highest peak in the beautiful Cascade Range.
He was also an executive at Microvision, Inc., a pioneer in optical beam-scanning display and imaging systems, where he led corporate development as the company progressed from bench-stage technology to product introduction. While there he also founded Lumera Corporation, a developer of optical communications and biomedical analysis devices based on proprietary nanomaterials. He served in a senior leadership capacity as both businesses grew to become successful publicly listed companies.
Todd holds an MBA from Stanford University and a BA from Hendrix College.